DUAL ANTIGEN TARGETING WITH CO-TRANSDUCED CD19/22 CAR T CELLS MAY PREVENT ANTIGEN-NEGATIVE RELAPSE AFTER CAR T CELL THERAPY FOR RELAPSED/REFRACTORY ALL

被引:0
|
作者
Lucchini, Giovanna [1 ]
Ghorashian, Sara [1 ]
Richardson, Rachel [2 ]
Nguyen, Kyvi [2 ]
Terris, Craig [2 ]
Espuelas, Macarena Oporto [2 ]
Yeung, Jenny
Chu, Jan [1 ]
Williams, Lindsey [1 ]
Ko, Kaye [1 ]
Walding, Chloe [3 ]
Watts, Kelly [4 ]
Inglott, Sarah [1 ]
Adams, Stuart [1 ]
Gravett, Emma [1 ]
Gilmour, Kimberly [1 ]
Lal, Alka [5 ]
Kunaseelan, Sangeetha [5 ]
Popova, Bilyana [5 ]
Lopes, Andre [5 ]
Ngai, Yenting [5 ]
Kokalaki, Eva [6 ]
Carulla, Milena Balasch [1 ]
Mullanfiroze, Khushnuma [1 ]
Lazareva, Arina [1 ]
Chiesa, Robert [1 ]
Silva, Juliana [1 ]
Rao, Kanchan [1 ]
Bonney, Denise [4 ]
Wynn, Robert [4 ]
Pule, Martin [6 ]
Hough, Rachael [3 ]
Amrolia, Persis [1 ]
机构
[1] Great Ormond St Hosp NHS Fdn Trust, London, England
[2] UCL Great Ormond St Inst Child Hlth, London, England
[3] Univ Coll London Hosp NHS Trust, London, England
[4] Royal Manchester Childrens Hosp, Manchester, Lancs, England
[5] Canc Res UK & UCL Canc Trials Ctr, London, England
[6] Autolus Ltd, London, England
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
O036
引用
收藏
页码:42 / 42
页数:1
相关论文
共 50 条
  • [41] Bispecific CAR T cell therapy targeting BCMA and CD19 in relapsed/refractory multiple myeloma: a phase I/II trial
    Shi, Ming
    Wang, Jiaojiao
    Huang, Hongming
    Liu, Dan
    Cheng, Hai
    Wang, Xu
    Chen, Wei
    Yan, Zhiling
    Sang, Wei
    Qi, Kunming
    Li, Depeng
    Zhu, Feng
    Li, Zhenyu
    Qiao, Jianlin
    Wu, Qingyun
    Zeng, Lingyu
    Fei, Xiaoming
    Gu, Weiying
    Miao, Yuqing
    Xu, Kailin
    Zheng, Junnian
    Cao, Jiang
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [42] IKAROS MEDIATES ANTIGEN ESCAPE FOLLOWING CD19 CAR T CELL THERAPY IN R/R B-ALL
    Domizi, Pablo
    Sarno, Jolanda
    Jager, Astraea
    Rotiroti, Maria Caterina
    Baskar, Reema
    Reynolds, Warren
    Sahaf, Bita
    Bendall, Sean
    Mullighan, Charles
    Leahy, Allison
    Myers, Regina
    Grupp, Stephan
    Majzner, Robbie
    Sotillo, Elena
    Barrett, David
    Davis, Kara
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [43] Efficacy and Safety of Chimeric Antigen Receptor T Cells Therapy Strategy That Dual Targeting CD19 and CD22 to Treat Relapsed/Refractory Acute Lymphoblastic Leukemia in Adults
    Tu, Sanfang
    Zhou, Lijuan
    Huang, Rui
    Zhou, Xuan
    Yang, Jilong
    Li, Meifang
    Jin, Bo
    Wang, Langqi
    Zhuo, Yaqi
    Chen, Huifang
    Chang, Lung-Ji
    Li, Yuhua
    BLOOD, 2023, 142
  • [44] Ikaros Mediates Antigen Escape Following CD19 CAR T Cell Therapy in r/r B-ALL
    Domizi, Pablo
    Sarno, Jolanda
    Jager, Astraea
    Baskar, Reema
    Reynolds, Warren D.
    Sahaf, Bita
    Bendall, Sean
    Mullighan, Charles G.
    Leahy, Allison Barz
    Myers, Regina M.
    Grupp, Stephan A.
    Sotillo, Elena
    Barrett, David
    Davis, Kara L.
    BLOOD, 2021, 138
  • [45] Sustained remissions with CD19-specific chimeric antigen receptor (CAR)-modified T cells in children with relapsed/refractory ALL
    Maude, Shannon L.
    Teachey, David T.
    Rheingold, Susan R.
    Shaw, Pamela A.
    Aplenc, Richard
    Barrett, David Maxwell
    Barker, Christine S.
    Callahan, Colleen
    Frey, Noelle V.
    Nazimuddin, Farzana
    Lacey, Simon F.
    Zheng, Zhaohui
    Levine, Bruce
    Melenhorst, Jan Joseph
    Motley, Laura
    Porter, David L.
    June, Carl H.
    Grupp, Stephan A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [46] Chimeric Antigen Receptor (CAR) T Cells: Lessons Learned from Targeting of CD19 in B-Cell Malignancies
    Hay, Kevin A.
    Turtle, Cameron J.
    DRUGS, 2017, 77 (03) : 237 - 245
  • [47] Treatment and outcomes of patients with B-ALL relapse after CD19 CAR-T therapy
    Wang, Yu
    Xue, Yu-juan
    Zuo, Ying-xi
    Jia, Yue-ping
    Lu, Ai-dong
    Zeng, Hui-min
    Zhang, Le-ping
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [48] Chimeric Antigen Receptor (CAR) T Cells: Lessons Learned from Targeting of CD19 in B-Cell Malignancies
    Kevin A. Hay
    Cameron J. Turtle
    Drugs, 2017, 77 : 237 - 245
  • [49] Overcoming CD19 Antigen Loss in B-Cell Malignancies with CAR T Cells Targeting BAFF-R
    Qin, Hong
    Dong, Zhenyuan
    Wang, Xiuli
    Cheng, Wesley
    Smith, Diane Lynne
    Song, Joo Y.
    Aldoss, Ibrahim
    Forman, Stephen J.
    Kwak, Larry W.
    BLOOD, 2019, 134
  • [50] CAR T cells targeting BAFF-R can overcome CD19 antigen loss in B cell malignancies
    Qin, Hong
    Dong, Zhenyuan
    Wang, Xiuli
    Cheng, Wesley A.
    Wen, Feng
    Xue, Weili
    Sun, Han
    Walter, Miriam
    Wei, Guowei
    Smith, D. Lynne
    Sun, Xiuhua
    Fei, Fan
    Xie, Jianming
    Panagopoulou, Theano I.
    Chen, Chun-Wei
    Song, Joo Y.
    Aldoss, Ibrahim
    Kayembe, Clarisse
    Sarno, Luisa
    Muschen, Markus
    Inghirami, Giorgio G.
    Forman, Stephen J.
    Kwak, Larry W.
    SCIENCE TRANSLATIONAL MEDICINE, 2019, 11 (511)